Trial intelligence / Profile preview

Phase 2 study of sildenafil on circulatory and respiratory physiological phenomena

2013-000014-38Phase 2Completed

Sponsor
CHU Grenoble Alpes
Start
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of sildenafil in cardiac morbidity and respiratory physiological phenomena, sponsored by CHU Grenoble Alpes. Started Sep 2015; status: completed.

02

Drugs

sildenafil
03

Conditions

cardiac morbidityrespiratory physiological phenomena

Beyond the preview

Go deeper on 2013-000014-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000014-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call